Unichem Laboratories, a Rs.790 crore Mumbai based pharma major, has registered strong growth in top line and bottom line during the first quarter ended June 2012. Its net profit has taken quantum jump of 112.2 per cent to Rs.33.14 crore from Rs.15.62 crore in the corresponding period of last year. Its net sales also went up by 41.1 per cent Rs.263.30 crore from Rs.186.68 crore. EBDITA increased by 90.2 per cent to Rs.54.67 crore from Rs.28.74 crore. The earnings per share for face value of Rs.2 per share worked out to Rs.3.67 as against Rs.1.73 in the last period.

The board of directors has recommended equity dividend of 150 per cent for the year 2011-12. Its domestic sales increased by 22.7 per cent to Rs.176.57 crore from Rs.143.93 crore and that in international market went up by 97 per cent to Rs.88.29 crore from Rs.44.82 crore in the similar quarter of last year.

Meanwhile, Unichem has appointed Bhagwat S Dhingra as chief executive - domestic pharma, in place of Harcharan Singh, with effect from August 06, 2012. Harcharan Singh will be in an advisory role for some time and thereafter will be looking for entrepreneurial opportunities.